| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cc79ee5ce95c471238634548dbc14b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfec8e1fc8df776b09d5792e6b2a4849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b64015760f42e9048545d5259f9a2f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_142f4514e232c5a93f4f673ce6982038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98a5671904c4599e077e12afdd26b409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf28904d67924910620f7154a329f543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37e810f045386d2044b2041f92347dab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd6327d29eb6e3c069d5f663ddf084e9 |
| publicationDate |
2021-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210084053-A |
| titleOfInvention |
Pharmaceutical composite formulation comprising empagliflozin and metformin and method for manufacturing the same |
| abstract |
The present invention relates to a pharmaceutical combination formulation comprising an empagliflozin immediate-release layer and a metformin sustained-release layer, and a method for preparing the same, and more particularly, to an empagliflozin immediate-release layer and a sustained-release formulation comprising an immediate-release formulation The present invention relates to a pharmaceutical combination formulation of a two-layer tablet formulation comprising a metformin sustained-release layer containing a release agent and a method for preparing the same. |
| priorityDate |
2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |